- Home
- / Nascent Biotech
Nascent Biotech
Stock Price
$0.1
2024-10-29
Market Capitalization
$13.8 M
2024-10-29
Revenue
$1 M
FY, 2022
Nascent Biotech Summary
Company Summary
- Overview
- Nascent Biotech is a biotechnology company specializing in monoclonal antibodies. It focuses on the development and delivery of human antibodies and cytokine responses for the treatment of cancer.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- San Diego, CA, US | view all locations
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Lowell Holden, Chief Financial Officer and Chief Accounting Officer
LocationsView all
1 location detected
San Diego, CA HQ
United States
6330 Nancy Ridge Dr #105
Nascent Biotech Financials
Summary Financials
- Net income (Q1, 2025)
- $377.4K
- Cash (Q1, 2025)
- $47.4K
- EBIT (Q1, 2025)
- ($375.7K)
- Enterprise value
- $13.8M